Dermata Therapeutics, Inc. (DRMAW) News
Follow Dermata Therapeutics, Inc. (DRMAW) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Dermata Therapeutics launches Tome foundational treatment commercially
Dermata Therapeutics (DRMAW) announces the commercial launch of its Tome foundational treatment.
EQUITY | Aug 25, 2026, 12:30 PM UTC
L
Dermata (DRMAW) opens preorders for Tome treatment
Dermata announces preorders are now open for its Tome foundational treatment ahead of its commercial launch, with no additional financial figures or pricing details provided in the feed.
EQUITY | Aug 21, 2026, 12:30 PM UTC
L
DRMA DRMAW - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
DRMA DRMAW - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
EARNINGS | Aug 11, 2026, 08:05 PM UTC